Cladribine 3.5 mg/kg ( DrugBank: Cladribine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00213135 (ClinicalTrials.gov)	April 2005	13/9/2005	A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Scleros ...	A Phase III, Randomized, Double-blind, Three-arm, Placebo-controlled, Multi-center Study to Evaluate ...	Multiple Sclerosis, Relapsing-Remitting	Drug: Cladribine 5.25 mg/kg;Drug: Cladribine 3.5 mg/kg;Other: Placebo	EMD Serono	NULL	Completed	18 Years	65 Years	All	1326	Phase 3	Canada;Switzerland

First Previous1Next Last